A detailed history of Western Pacific Wealth Management, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Western Pacific Wealth Management, LP holds 973 shares of ABBV stock, worth $175,140. This represents 0.13% of its overall portfolio holdings.

Number of Shares
973
Previous 973 -0.0%
Holding current value
$175,140
Previous $166,000 15.66%
% of portfolio
0.13%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $21,599 - $26,878
-163 Reduced 14.35%
973 $131,000
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $14,461 - $16,654
100 Added 9.65%
1,136 $181,000
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $4,287 - $5,141
31 Added 3.08%
1,036 $167,000
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $78,244 - $89,741
583 Added 138.15%
1,005 $134,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $45,335 - $57,362
422 New
422 $57,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Western Pacific Wealth Management, LP Portfolio

Follow Western Pacific Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Pacific Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Western Pacific Wealth Management, LP with notifications on news.